211 related articles for article (PubMed ID: 10510335)
1. The soluble CD40 ligand sCD154 in systemic lupus erythematosus.
Kato K; Santana-Sahagún E; Rassenti LZ; Weisman MH; Tamura N; Kobayashi S; Hashimoto H; Kipps TJ
J Clin Invest; 1999 Oct; 104(7):947-55. PubMed ID: 10510335
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera.
Vakkalanka RK; Woo C; Kirou KA; Koshy M; Berger D; Crow MK
Arthritis Rheum; 1999 May; 42(5):871-81. PubMed ID: 10323442
[TBL] [Abstract][Full Text] [Related]
3. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
Grammer AC; Slota R; Fischer R; Gur H; Girschick H; Yarboro C; Illei GG; Lipsky PE
J Clin Invest; 2003 Nov; 112(10):1506-20. PubMed ID: 14617752
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
5. Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus.
Harigai M; Hara M; Fukasawa C; Nakazawa S; Kawaguchi Y; Kamatani N; Kashiwazaki S
Lupus; 1999; 8(3):227-33. PubMed ID: 10342716
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD154 is not associated with atherosclerosis in systemic lupus erythematosus.
Kiani A; Mahoney JA; Petri M
J Rheumatol; 2007 May; 34(5):969-72. PubMed ID: 17407217
[TBL] [Abstract][Full Text] [Related]
7. Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40.
Delmas Y; Viallard JF; Solanilla A; Villeneuve J; Pasquet JM; Belloc F; Dubus I; Déchanet-Merville J; Merville P; Blanco P; Pellegrin JL; Nurden AT; Combe C; Ripoche J
Kidney Int; 2005 Nov; 68(5):2068-78. PubMed ID: 16221206
[TBL] [Abstract][Full Text] [Related]
8. Total and biologically active CD154 in patients with SLE.
de Sanctis JB; Garmendia JV; Chaurio R; Zabaleta M; Rivas L
Autoimmunity; 2009 May; 42(4):263-5. PubMed ID: 19811271
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
Koshy M; Berger D; Crow MK
J Clin Invest; 1996 Aug; 98(3):826-37. PubMed ID: 8698875
[TBL] [Abstract][Full Text] [Related]
11. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Dejica DI; Manea EM
Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
[TBL] [Abstract][Full Text] [Related]
12. Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population.
Xiang Y; Guo J; Peng YF; Huang HT; Lan Y; Wei YS
Rheumatol Int; 2017 Aug; 37(8):1287-1294. PubMed ID: 28550400
[TBL] [Abstract][Full Text] [Related]
13. Platelet membrane CD154 and sCD154 in progressive peripheral arterial disease: a pilot study.
Young RS; Naseem KM; Pasupathy S; Ahilathirunayagam S; Chaparala RP; Homer-Vanniasinkam S
Atherosclerosis; 2007 Feb; 190(2):452-8. PubMed ID: 16777115
[TBL] [Abstract][Full Text] [Related]
14. CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.
Néron S; Boire G; Dussault N; Racine C; de Brum-Fernandes AJ; Côté S; Jacques A
Arch Immunol Ther Exp (Warsz); 2009; 57(6):447-58. PubMed ID: 19866343
[TBL] [Abstract][Full Text] [Related]
15. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.
Toubi E; Shoenfeld Y
Autoimmunity; 2004; 37(6-7):457-64. PubMed ID: 15621572
[TBL] [Abstract][Full Text] [Related]
16. [Effect of prolactin on CD40/CD154 expression on peripheral blood mononuclear cells in patients with systemic lupus erythematosus].
Wang N; Peng XB; Zeng K
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1382-4. PubMed ID: 17884785
[TBL] [Abstract][Full Text] [Related]
17. PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway.
Oxer DS; Godoy LC; Borba E; Lima-Salgado T; Passos LA; Laurindo I; Kubo S; Barbeiro DF; Fernandes D; Laurindo FR; Velasco IT; Curi R; Bonfa E; Souza HP
Lupus; 2011 May; 20(6):575-87. PubMed ID: 21415255
[TBL] [Abstract][Full Text] [Related]
18. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
Desai-Mehta A; Lu L; Ramsey-Goldman R; Datta SK
J Clin Invest; 1996 May; 97(9):2063-73. PubMed ID: 8621796
[TBL] [Abstract][Full Text] [Related]
19. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus.
Vlachoyiannopoulos PG; Mavragani CP; Bourazopoulou E; Balitsari AV; Routsias JG
Thromb Haemost; 2004 Dec; 92(6):1303-11. PubMed ID: 15583738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
